Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison

Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endosc...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 12; no. 6; pp. 838 - 848
Main Authors Li, Wanpeng, Liu, Qiang, Wang, Huan, Zhang, Huangkang, Liu, Quan, Hu, Li, Li, Houyong, Dai, Jiong, Sun, Xicai, Yu, Hongmeng, Wang, Dehui
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
AbstractList The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well-balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment-related complications were compared between the 2 groups. The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow-up of 15 (range, 2-63) months, the 2-year overall survival and progression-free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment-related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment-related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
BACKGROUNDThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. METHODSWe enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well-balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment-related complications were compared between the 2 groups. RESULTSThe cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow-up of 15 (range, 2-63) months, the 2-year overall survival and progression-free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment-related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). CONCLUSIONThe innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment-related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
Abstract Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p  = 0.022 and p  = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group ( p  = 0.001, p  = 0.014, and p  = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
Author Wang, Huan
Yu, Hongmeng
Li, Wanpeng
Zhang, Huangkang
Sun, Xicai
Dai, Jiong
Liu, Quan
Liu, Qiang
Hu, Li
Wang, Dehui
Li, Houyong
Author_xml – sequence: 1
  givenname: Wanpeng
  surname: Li
  fullname: Li, Wanpeng
  organization: Fudan University
– sequence: 2
  givenname: Qiang
  surname: Liu
  fullname: Liu, Qiang
  organization: Fudan University
– sequence: 3
  givenname: Huan
  surname: Wang
  fullname: Wang, Huan
  organization: Fudan University
– sequence: 4
  givenname: Huangkang
  surname: Zhang
  fullname: Zhang, Huangkang
  organization: Fudan University
– sequence: 5
  givenname: Quan
  surname: Liu
  fullname: Liu, Quan
  organization: Fudan University
– sequence: 6
  givenname: Li
  surname: Hu
  fullname: Hu, Li
  organization: Fudan University
– sequence: 7
  givenname: Houyong
  surname: Li
  fullname: Li, Houyong
  organization: Fudan University
– sequence: 8
  givenname: Jiong
  surname: Dai
  fullname: Dai, Jiong
  organization: Shanghai Jiaotong University School of Medicine
– sequence: 9
  givenname: Xicai
  surname: Sun
  fullname: Sun, Xicai
  email: laryngeal@163.com
  organization: Fudan University
– sequence: 10
  givenname: Hongmeng
  surname: Yu
  fullname: Yu, Hongmeng
  email: hongmengyush@163.com
  organization: Chinese Academy of Medical Sciences
– sequence: 11
  givenname: Dehui
  orcidid: 0000-0003-0346-3193
  surname: Wang
  fullname: Wang, Dehui
  email: wangdehuient@sina.com
  organization: Fudan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34773719$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9qFTEUxoNUbK1d-AIScKOL207-T9xdStXCBaHoesjkT5uSScZk5sp15SP0OXwsn8S00xYUms13TvLjO5x8L8FeTNEC8Bo1x6hp8IkK-RhjicUzcIAbildctnTvsRZ8HxyVct3UwxBjSLwA-4QKQQSSB-D3eYxpqya_tVCNY_C61inC5KCPk81RBahVTpM3UOV6sYN26FPwPxfOR1hU2KpLC200qeg0eg2jKmm8UnkXL62e0rCDLmWYrZ5ztnH6530ZoH1Mg_oA17Up9s-vm0FN-soaqNMwquxLiq_Ac6dCsUf3egi-fTz7evp5tfny6fx0vVlpwohYcUxIL3mPMKbMcYawky1Xoq1CVE_r2s453IqWit4Yh4zkFAtOTIMMRQ05BO8W3zGn77MtUzf4om0IKto0lw4zKahEVMiKvv0PvU7z7Z9VinNCOWMtrtT7hdI5lZKt68bsh7p9h5ruNsOuZtjdZVjZN_eOcz9Y80g-JFaBkwX44YPdPe3UrTcXi-VfmSGr6A
CitedBy_id crossref_primary_10_1002_alr_22981
crossref_primary_10_1186_s12885_023_11760_y
crossref_primary_10_1016_j_cson_2023_100018
crossref_primary_10_1002_alr_22979
crossref_primary_10_1002_hed_27244
crossref_primary_10_1002_alr_23051
crossref_primary_10_2147_CMAR_S409091
crossref_primary_10_1002_adfm_202209413
Cites_doi 10.1007/s11912-020-00949-0
10.1016/j.ijrobp.2010.03.024
10.1177/1945892420964054
10.1007/s00270-005-0367-7
10.3389/fonc.2020.00437
10.3322/caac.21492
10.1016/j.amjoto.2020.102860
10.1038/s41571-021-00524-x
10.1007/s10147-017-1143-9
10.1177/0194599815616799
10.3389/fonc.2021.674889
10.3171/jns.1974.41.2.0125
10.1093/neuros/nyx075
10.1002/hed.24234
10.1016/S1470-2045(20)30673-2
10.1016/j.oraloncology.2020.104922
10.3389/fonc.2021.716729
10.1002/hed.20161
10.1097/00005537-200003000-00010
10.3171/2012.9.JNS12332
ContentType Journal Article
Copyright 2021 ARS‐AAOA, LLC.
2021 ARS-AAOA, LLC.
2022 ARS‐AAOA, LLC.
Copyright_xml – notice: 2021 ARS‐AAOA, LLC.
– notice: 2021 ARS-AAOA, LLC.
– notice: 2022 ARS‐AAOA, LLC.
DBID NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1002/alr.22927
DatabaseName PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2042-6984
EndPage 848
ExternalDocumentID 10_1002_alr_22927
34773719
ALR22927
Genre article
Journal Article
GroupedDBID ---
05W
0R~
1OC
31~
33P
4.4
50Y
52T
52V
53G
7PT
8-0
8-1
A00
AAESR
AAHHS
AANLZ
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
D-A
DCZOG
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
FEDTE
FUBAC
G-S
GODZA
HGLYW
HVGLF
HZ~
KBYEO
LATKE
LEEKS
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY.
MY~
O9-
OVD
P2W
P4E
PQQKQ
ROL
RX1
SUPJJ
TEORI
WBKPD
WOHZO
WXSBR
WYJ
ZZTAW
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c3537-6233b96b12245f6512f986a78f983ab4719fff287847bddf1d9642763d01d4103
ISSN 2042-6976
IngestDate Fri Aug 16 06:08:50 EDT 2024
Thu Oct 10 17:45:11 EDT 2024
Fri Aug 23 01:33:27 EDT 2024
Wed Oct 16 00:40:34 EDT 2024
Sat Aug 24 00:59:41 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords recurrent nasopharyngeal carcinoma
internal carotid artery
salvage surgery
embolization
survival
Language English
License 2021 ARS-AAOA, LLC.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3537-6233b96b12245f6512f986a78f983ab4719fff287847bddf1d9642763d01d4103
Notes Additional Supporting Information may be found in the online version of this article.
Wanpeng Li and Qiang Liu contributed equally to this work.
Potential conflict of interest: None provided.
View this article online at wileyonlinelibrary.com.
Funding sources for the study: National Natural Science Foundation of China (No. 81870703); Shanghai Shen Kang Hospital Development Center (SHDC12018118); Clinical Research Plan of the SHDC (SHDC2020CR2005A); Shanghai Science and Technology Committee Foundation (19411950600); New Technologies of Endoscopic Surgery in Skull Base Tumor, CAMS innovation Fund for Medical Sciences (2019‐12 M‐5‐003); Science and Technology Commission of Shanghai Municipality (20Y11902000, 21ZR1411700); Shanghai Municipal Health Commission (201940143).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0346-3193
PMID 34773719
PQID 2663465582
PQPubID 996378
PageCount 11
ParticipantIDs proquest_miscellaneous_2597491479
proquest_journals_2663465582
crossref_primary_10_1002_alr_22927
pubmed_primary_34773719
wiley_primary_10_1002_alr_22927_ALR22927
PublicationCentury 2000
PublicationDate June 2022
2022-Jun
2022-06-00
20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International forum of allergy & rhinology
PublicationTitleAlternate Int Forum Allergy Rhinol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 35
2021; 42
2021; 22
2021; 11
2017; 81
1974; 41
2011; 80
2021; 18
2017; 22
2013; 118
2006; 29
2016; 154
2020; 111
2000; 110
1994; 15
2020; 22
2020; 10
2005; 26
2005; 27
2016; 38
2018; 68
Abud DG (e_1_2_6_15_1) 2005; 26
e_1_2_6_10_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
e_1_2_6_4_1
Linskey ME (e_1_2_6_21_1) 1994; 15
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_22_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_16_1
References_xml – volume: 26
  start-page: 2602
  year: 2005
  end-page: 2609
  article-title: Venous phase timing during balloon test occlusion as a criterion for permanent internal carotid artery sacrifice
  publication-title: AJNR Am J Neuroradiol
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 80
  start-page: 661
  year: 2011
  end-page: 668
  article-title: How does intensity‐modulated radiotherapy versus conventional two‐dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 81
  start-page: 672
  year: 2017
  end-page: 679
  article-title: Graft occlusion and graft size changes in complex internal carotid artery aneurysm treated by extracranial to intracranial bypass using high‐flow grafts with therapeutic internal carotid artery occlusion
  publication-title: Neurosurgery
– volume: 22
  start-page: 834
  year: 2017
  end-page: 842
  article-title: Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10‐year experience
  publication-title: Int J Clin Oncol
– volume: 29
  start-page: 958
  year: 2006
  end-page: 968
  article-title: Covered stent‐graft treatment of traumatic internal carotid artery pseudoaneurysms: a review
  publication-title: Cardiovasc Intervent Radiol
– volume: 15
  start-page: 829
  year: 1994
  end-page: 843
  article-title: Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon‐enhanced CT
  publication-title: AJNR Am J Neuroradiol
– volume: 27
  start-page: 397
  year: 2005
  end-page: 405
  article-title: Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group
  publication-title: Head Neck
– volume: 10
  start-page: 437
  year: 2020
  article-title: Quality of life following salvage endoscopic nasopharyngectomy in patients with recurrent nasopharyngeal carcinoma: a prospective study
  publication-title: Front Oncol
– volume: 35
  start-page: 458
  year: 2021
  end-page: 466
  article-title: Salvage endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: prognostic factors and treatment outcomes
  publication-title: Am J Rhinol Allergy
– volume: 111
  year: 2020
  article-title: A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery
  publication-title: Oral Oncol
– volume: 154
  start-page: 377
  year: 2016
  end-page: 382
  article-title: Eustachian tube as a landmark to the internal carotid artery in endoscopic skull base surgery
  publication-title: Otolaryngol Head Neck Surg
– volume: 41
  start-page: 125
  year: 1974
  end-page: 145
  article-title: Balloon catheterization and occlusion of major cerebral vessels
  publication-title: J Neurosurg
– volume: 38
  start-page: E1404
  issue: 1
  year: 2016
  end-page: 1412
  article-title: Extracranial/intracranial vascular bypass and craniofacial resection: new hope for patients with locally advanced recurrent nasopharyngeal carcinoma
  publication-title: Head Neck
– volume: 42
  year: 2021
  article-title: Clinical efficacy of bypass grafting in recurrent nasopharyngeal carcinoma patients with internal carotid artery invasion
  publication-title: Am J Otolaryngol
– volume: 22
  start-page: 86
  year: 2020
  article-title: The management of rNPC: salvage surgery vs. re‐irradiation
  publication-title: Curr Oncol Rep
– volume: 110
  start-page: 386
  year: 2000
  end-page: 390
  article-title: Assessment of carotid artery invasion in patients with head and neck cancer
  publication-title: Laryngoscope
– volume: 22
  start-page: 381
  year: 2021
  end-page: 390
  article-title: Endoscopic surgery compared with intensity‐modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open‐label, randomised, controlled, phase 3 trial
  publication-title: Lancet Oncol
– volume: 118
  start-page: 637
  year: 2013
  end-page: 642
  article-title: Cerebral revascularization and carotid artery resection at the skull base for treatment of advanced head and neck malignancies
  publication-title: J Neurosurg
– volume: 11
  year: 2021
  article-title: Clinical outcomes of salvage endoscopic nasopharyngectomy for patients with advanced recurrent nasopharyngeal carcinoma
  publication-title: Front Oncol
– volume: 11
  year: 2021
  article-title: Balloon test occlusion of internal carotid artery in recurrent nasopharyngeal carcinoma before endoscopic nasopharyngectomy: a single center experience
  publication-title: Front Oncol
– volume: 18
  start-page: 679
  year: 2021
  end-page: 695
  article-title: Nasopharyngeal carcinoma: an evolving paradigm
  publication-title: Nat Rev Clin Oncol
– ident: e_1_2_6_6_1
  doi: 10.1007/s11912-020-00949-0
– volume: 15
  start-page: 829
  year: 1994
  ident: e_1_2_6_21_1
  article-title: Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon‐enhanced CT
  publication-title: AJNR Am J Neuroradiol
  contributor:
    fullname: Linskey ME
– ident: e_1_2_6_5_1
  doi: 10.1016/j.ijrobp.2010.03.024
– ident: e_1_2_6_7_1
  doi: 10.1177/1945892420964054
– ident: e_1_2_6_18_1
  doi: 10.1007/s00270-005-0367-7
– ident: e_1_2_6_8_1
  doi: 10.3389/fonc.2020.00437
– ident: e_1_2_6_2_1
  doi: 10.3322/caac.21492
– ident: e_1_2_6_23_1
  doi: 10.1016/j.amjoto.2020.102860
– ident: e_1_2_6_3_1
  doi: 10.1038/s41571-021-00524-x
– ident: e_1_2_6_11_1
  doi: 10.1007/s10147-017-1143-9
– ident: e_1_2_6_13_1
  doi: 10.1177/0194599815616799
– ident: e_1_2_6_17_1
  doi: 10.3389/fonc.2021.674889
– ident: e_1_2_6_16_1
  doi: 10.3171/jns.1974.41.2.0125
– ident: e_1_2_6_19_1
  doi: 10.1093/neuros/nyx075
– ident: e_1_2_6_22_1
  doi: 10.1002/hed.24234
– ident: e_1_2_6_10_1
  doi: 10.1016/S1470-2045(20)30673-2
– ident: e_1_2_6_9_1
  doi: 10.1016/j.oraloncology.2020.104922
– ident: e_1_2_6_14_1
  doi: 10.3389/fonc.2021.716729
– volume: 26
  start-page: 2602
  year: 2005
  ident: e_1_2_6_15_1
  article-title: Venous phase timing during balloon test occlusion as a criterion for permanent internal carotid artery sacrifice
  publication-title: AJNR Am J Neuroradiol
  contributor:
    fullname: Abud DG
– ident: e_1_2_6_4_1
  doi: 10.1002/hed.20161
– ident: e_1_2_6_12_1
  doi: 10.1097/00005537-200003000-00010
– ident: e_1_2_6_20_1
  doi: 10.3171/2012.9.JNS12332
SSID ssj0000515517
Score 2.3664043
Snippet Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients...
The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors...
Abstract Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC)...
BackgroundThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients...
BACKGROUNDThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 838
SubjectTerms Carotid arteries
Carotid artery
Embolization
Endoscopy
Hemorrhage
internal carotid artery
Medical prognosis
Nasopharyngeal carcinoma
Patients
recurrent nasopharyngeal carcinoma
salvage surgery
Surgery
Survival
Throat cancer
Tumors
Title Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falr.22927
https://www.ncbi.nlm.nih.gov/pubmed/34773719
https://www.proquest.com/docview/2663465582
https://search.proquest.com/docview/2597491479
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHcKAxnEA1LV0djNxbx1wDTQhgTatL1FdpyUijaZunbSeOIn8Dv4VYhfwjm24yYUpMFLGp0kdaPz9dx8LoQ8i5kCtREO-oIBG4YiDvpyIJN-EoZax-CwhAKrkQ_eR3tHw3cn4Umn86ORtbRcqO3syx_rSv6Hq0ADvmKV7D9w1n8pEOAc-AtH4DAcL8Xjt26k6Xnea2xE110gjKGJY3kWE90zqZsXvXymqqkrvcRQx5mcnmPWTl7qCgtUJlmvlDjZQM4vyjFG9Gc2o3OOcXnTyal53S6QTcpqJm2NewZa0SdQgDUMmNAu0R3zlpq2cDsYabpCmKwELE4c20Se-adJO-6_b5IPjmV5mjuVa4hLpH4ApHvasYuD7y1X8PfBcSSOP9d3u5gHuMs-N8uKRoZFRZGIXRPtJs0OnPOynTUw3BTUie0pU-t82-1zTZ3Y9rRyOt9mTNgeBu2W3b-pUp_gaJtBsxQeTc2jV8gmA1EIMnhztPN6Z9fHAe2MHazq9y9VN8AasBd-6bbZtOYLtV0rYxsd3iDXnVNDRxahN0knL2-RqwcubeM2-b4CKm0AlVYFrYFKHVCpBSptAhVuog6odAVUugZUChiiHqi0DVTqgfqSjijC9OfXbw6gdAXQO-Ro983hq72-GxLSz3iIJa6McyUihTvEYRGB_VqIJJJxAh9cKrC9RFEULInBDFNaF4EW4HKDVtWDQA-DAb9LNsqqzO8TKjmX4NBEimdg5yomAwkOd8gjFXJdJKJLntY8SE9tL5h0jdFdslVzJ3Wi4iwFK5hjo8KEdckTfxkEOe7OyTKvlnAPuvYiGMawzj3LVb8KH8YxhzfpkueGzX9fPh3tfzQnDy7zYx-Sa6u_1xbZWMyX-SMwshfqscPpL-J02oU
link.rule.ids 315,783,787,27936,27937
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innovative+application+of+internal+carotid+artery+embolization+in+salvage+endoscopic+nasopharyngectomy+for+recurrent+nasopharyngeal+carcinoma%3A+A+case%E2%80%90matched+comparison&rft.jtitle=International+forum+of+allergy+%26+rhinology&rft.au=Li%2C+Wanpeng&rft.au=Liu%2C+Qiang&rft.au=Wang%2C+Huan&rft.au=Zhang%2C+Huangkang&rft.date=2022-06-01&rft.issn=2042-6976&rft.eissn=2042-6984&rft.volume=12&rft.issue=6&rft.spage=838&rft.epage=848&rft_id=info:doi/10.1002%2Falr.22927&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_alr_22927
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6976&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6976&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6976&client=summon